Cargando…

Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma

BACKGROUND: Frailty is a syndrome characterized by weakness, slow gait, weight loss, exhaustion, and low activity. We sought to determine whether frailty was associated with age or stage in newly diagnosed patients with pancreatic ductal adenocarcinoma (PDAC), and determine its association with surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngo‐Huang, An, Holmes, Holly M., des Bordes, Jude K. A., Parker, Nathan H., Fogelman, David, Petzel, Maria Q. B., Song, Juhee, Bruera, Eduardo, Katz, Matthew H. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558581/ https://www.ncbi.nlm.nih.gov/pubmed/31033241 http://dx.doi.org/10.1002/cam4.2157

Ejemplares similares

The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment
por: Parker, Nathan H., et al.
Publicado: (2021)

Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life
por: Ngo-Huang, An, et al.
Publicado: (2019)

Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients
por: Florez Bedoya, Claudia Alvarez, et al.
Publicado: (2019)

Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
por: Mohindroo, Chirayu, et al.
Publicado: (2021)

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
por: Rogers, Jane E., et al.
Publicado: (2020)

Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
por: Du, Jiali, et al.
Publicado: (2020)

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes
por: O'Reilly, Eileen M., et al.
Publicado: (2020)

Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures
por: Kim, Jungsun, et al.
Publicado: (2021)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery
por: Cameron, Miles E., et al.
Publicado: (2021)

Appendiceal adenocarcinoma is associated with better prognosis than cecal adenocarcinoma: a population-based comparative survival study
por: Chen, George, et al.
Publicado: (2023)

Real‐world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2021)

KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas
por: Diehl, Adam C, et al.
Publicado: (2022)

Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma
por: Naso, Julia R., et al.
Publicado: (2020)

Neutrophil–lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Xiang, Zi-jun, et al.
Publicado: (2020)

Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma
por: Canton, Clémence, et al.
Publicado: (2022)

Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival
por: El Jellas, Khadija, et al.
Publicado: (2017)

Pancreas Cancer‐Associated Weight Loss
por: Hendifar, Andrew E., et al.
Publicado: (2018)

Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma
por: Li, Ge, et al.
Publicado: (2020)

End‐of‐Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs
por: Dalal, Shalini, et al.
Publicado: (2017)

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
por: Lau, Allison N, et al.
Publicado: (2020)

The impact of expanding health insurance coverage for anti‐cancer drugs on cancer survival in Korea
por: Cho, Do‐Yeon, et al.
Publicado: (2021)

Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
por: Li, Tianjiao, et al.
Publicado: (2019)

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
por: Croft, Wayne, et al.
Publicado: (2023)

Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer
por: Liu, Bo, et al.
Publicado: (2021)

Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
por: Xie, Shao‐Hua, et al.
Publicado: (2020)

Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma
por: Yu, Xiang, et al.
Publicado: (2017)

Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years
por: Pellat, Anna, et al.
Publicado: (2022)

Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma
por: Hegewisch‐Becker, Susanna, et al.
Publicado: (2018)

Prediagnostic adult body mass index change and esophageal adenocarcinoma survival
por: Loehrer, Elizabeth A., et al.
Publicado: (2020)

Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas
por: Fujiwara, Sho, et al.
Publicado: (2019)

Cancer‐associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma
por: Zhang, Aibin, et al.
Publicado: (2017)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice
por: Fielder, Edward, et al.
Publicado: (2022)

Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer
por: Schniers, Bradley K., et al.
Publicado: (2022)

Compassion is a key quality for palliative care teams
por: Kang, Jung Hun, et al.
Publicado: (2018)

Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity
por: Schmuck, Rosa B., et al.
Publicado: (2015)

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
por: Cremin, Carol, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States
por: Paluri, Ravi, et al.
Publicado: (2022)

Encouraging long‐term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high‐risk patients with resectable pancreatic carcinoma
por: AlMasri, Samer S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ord4jk3nblgoolrg1f67tcadro